US: Regeneron beats quarterly sales on COVID-19 drug demand
#1
Information 

A sharp surge in COVID-19 cases led by the Delta variant caused a "tremendous acceleration" in use of the cocktail, Regeneron Chief Executive Officer Leonard Schleifer had said in August.


https://www.reuters.com/business/healthc...021-11-04/
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)